These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 10529242)
21. A study in glycation of a therapeutic recombinant humanized monoclonal antibody: where it is, how it got there, and how it affects charge-based behavior. Quan C; Alcala E; Petkovska I; Matthews D; Canova-Davis E; Taticek R; Ma S Anal Biochem; 2008 Feb; 373(2):179-91. PubMed ID: 18158144 [TBL] [Abstract][Full Text] [Related]
22. Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody. Ryan AM; Eppler DB; Hagler KE; Bruner RH; Thomford PJ; Hall RL; Shopp GM; O'Neill CA Toxicol Pathol; 1999; 27(1):78-86. PubMed ID: 10367678 [TBL] [Abstract][Full Text] [Related]
23. Accessing the global minimum conformation of stefin A dimer by annealing under partially denaturing conditions. Jerala R; Zerovnik E J Mol Biol; 1999 Sep; 291(5):1079-89. PubMed ID: 10518944 [TBL] [Abstract][Full Text] [Related]
24. Isolation and characterization of neutralizing monoclonal antibodies to human vascular endothelial growth factor/vascular permeability factor121 (VEGF/VPF121). Asano M; Yukita A; Matsumoto T; Matsuo K; Kondo S; Suzuki H Hybridoma; 1995 Oct; 14(5):475-80. PubMed ID: 8575796 [TBL] [Abstract][Full Text] [Related]
25. Wide spectrum of antitumor activity of a neutralizing monoclonal antibody to human vascular endothelial growth factor. Asano M; Yukita A; Suzuki H Jpn J Cancer Res; 1999 Jan; 90(1):93-100. PubMed ID: 10076571 [TBL] [Abstract][Full Text] [Related]
26. Noncovalent interactions of the Apple 4 domain that mediate coagulation factor XI homodimerization. Dorfman R; Walsh PN J Biol Chem; 2001 Mar; 276(9):6429-38. PubMed ID: 11092900 [TBL] [Abstract][Full Text] [Related]
27. Unbinding of oxidized cytochrome c from photosynthetic reaction center of Rhodobacter sphaeroides is the bottleneck of fast turnover. Gerencsér L; Laczkó G; Maróti P Biochemistry; 1999 Dec; 38(51):16866-75. PubMed ID: 10606520 [TBL] [Abstract][Full Text] [Related]
28. Bovine β-lactoglobulin is dimeric under imitative physiological conditions: dissociation equilibrium and rate constants over the pH range of 2.5-7.5. Mercadante D; Melton LD; Norris GE; Loo TS; Williams MA; Dobson RC; Jameson GB Biophys J; 2012 Jul; 103(2):303-12. PubMed ID: 22853908 [TBL] [Abstract][Full Text] [Related]
29. Antibody to vascular endothelial growth factor slows growth of an androgen-independent xenograft model of prostate cancer. Fox WD; Higgins B; Maiese KM; Drobnjak M; Cordon-Cardo C; Scher HI; Agus DB Clin Cancer Res; 2002 Oct; 8(10):3226-31. PubMed ID: 12374693 [TBL] [Abstract][Full Text] [Related]
30. Treatment of metastatic colorectal cancer with monoclonal antibody to vascular endothelial growth factor: does the metastatic site make the difference? Graziano F; Cascinu S J Clin Oncol; 2003 Sep; 21(18):3542-3; author reply 3543. PubMed ID: 12972535 [No Abstract] [Full Text] [Related]
31. Trimerization Dictates Solution Opalescence of a Monoclonal Antibody. Yang TC; Langford AJ; Kumar S; Ruesch JC; Wang W J Pharm Sci; 2016 Aug; 105(8):2328-37. PubMed ID: 27373839 [TBL] [Abstract][Full Text] [Related]
32. Vascular endothelial growth factor as a marker of tumor endothelium. Brekken RA; Huang X; King SW; Thorpe PE Cancer Res; 1998 May; 58(9):1952-9. PubMed ID: 9581838 [TBL] [Abstract][Full Text] [Related]
33. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638 [TBL] [Abstract][Full Text] [Related]
34. Tumor angiogenesis and accessibility: role of vascular endothelial growth factor. Jain RK Semin Oncol; 2002 Dec; 29(6 Suppl 16):3-9. PubMed ID: 12516032 [TBL] [Abstract][Full Text] [Related]
35. An antibody to VEGF upregulates factor VIII via interleukin-1 in activated adrenal cortex-derived capillary endothelial cells. Li W; Keller GA Int Immunopharmacol; 2003 Apr; 3(4):493-512. PubMed ID: 12689655 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. Asano M; Yukita A; Matsumoto T; Kondo S; Suzuki H Cancer Res; 1995 Nov; 55(22):5296-301. PubMed ID: 7585591 [TBL] [Abstract][Full Text] [Related]
37. Thermodynamics of dimer and tetramer formations in rabbit muscle phosphofructokinase. Luther MA; Cai GZ; Lee JC Biochemistry; 1986 Dec; 25(24):7931-7. PubMed ID: 2948566 [TBL] [Abstract][Full Text] [Related]
38. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Gorski DH; Beckett MA; Jaskowiak NT; Calvin DP; Mauceri HJ; Salloum RM; Seetharam S; Koons A; Hari DM; Kufe DW; Weichselbaum RR Cancer Res; 1999 Jul; 59(14):3374-8. PubMed ID: 10416597 [TBL] [Abstract][Full Text] [Related]
39. A strategy for antitumor vascular therapy by targeting the vascular endothelial growth factor: receptor complex. Cooke SP; Boxer GM; Lawrence L; Pedley RB; Spencer DI; Begent RH; Chester KA Cancer Res; 2001 May; 61(9):3653-9. PubMed ID: 11325835 [TBL] [Abstract][Full Text] [Related]
40. Nonnative aggregation of an IgG1 antibody in acidic conditions, part 2: nucleation and growth kinetics with competing growth mechanisms. Brummitt RK; Nesta DP; Chang L; Kroetsch AM; Roberts CJ J Pharm Sci; 2011 Jun; 100(6):2104-19. PubMed ID: 21213307 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]